-transparent.png){kind=logo}
A retrospective analysis was performed of 118 surgically treated mammary recurrences, occurring following primary conservative excision and radiation therapy for clinical Stages I and II breast cancer. Actuarial cancer-specific survival following salvage surgery was 72% at 5 years and 58% at 10 years. With a median followup of 7 years, further local-regional recurrences were observed in 20 of the 118 patients, many of whom could be treated by further surgery. Actuarial survival after recurrence was significantly influenced by initial clinical stage, as well as by the disease-free interval following primary therapy, but was similar for both premenopausal and postmenopausal patients and for patients treated by radical or breast-conserving salvage operations. For recurrences after the fifth year, actuarial survival following salvage surgery was 83% and 68% at 5 and 10 years, respectively. Survival for Stage I patients was favorable regardless of disease-free interval. It is concluded that recurrences in the breast following primary treatment with limited surgery and irradiation have a considerably more favorable prognosis than that of local failures after primary radical surgery. Suggestions for the management of these recurrences are presented.
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
March 1993,
Cancer,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
October 1993,
Cancer,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
November 2005,
International journal of radiation oncology, biology, physics,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
December 2015,
Journal of breast cancer,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
June 2007,
Nihon rinsho. Japanese journal of clinical medicine,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
October 2013,
Annals of surgical oncology,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
December 1989,
Nederlands tijdschrift voor geneeskunde,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
January 2001,
Duodecim; laaketieteellinen aikakauskirja,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
January 2021,
Frontiers in oncology,
J M Kurtz, and
R Amalric, and
H Brandone, and
Y Ayme, and
J M Spitalier
September 1998,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
